Last updated: May 10, 2024
- Brand NamePharmEasy
- HeadquarterMumbai
- No. of Employees3689
- Industry
Healthcare
- Founded Year 2019
- Company StatusActive
- Highlights
- Total Funding₹8330.70 Cr
- Funding Rounds8
- Number of Acquisitions3
- FY 2022-23 Revenue₹6699.10 Cr
- FY 2022-23 Loss-₹5211.40 Cr
About PharmEasy
Launched in 2015, PharmEasy is pharmacy made easy! Started with the sole purpose of making healthcare accessible and affordable to all, PharmEasy today is India’s leading and most trusted online healthcare aggregator in the country. They help patients connect with local pharmacy stores and diagnostic centers to fulfill their extensive medical needs. They.....
Business Model of PharmEasy
PharmEasy is an online pharmacy company that offers a variety of pharmaceutical products. It provides services such as delivering products through delivery personnel, leasing software and hardware, warehousing, and earns commissions from facilitating diagnostic tests through its marketplace. It offers services like ordering medicine, healthcare products, and lab tests, along with a PharmEasy Plus membership that provides benefits like extra cashback, free delivery, and doctor teleconsultation.
Key People/Management
Show allSS
Siddharth Shah Co Founder & CEO
DD
Dr. Dhaval ShahCo-Founder
SB
Siddharth Bhaskar Shah Managing Director
HS
Harsh Shailesh Parekh Wholetime Director
DN
Dharmil Nirupam ShethWholetime Director
AP
Aditya PuriDirector
Top Competitors
NE
NetmedsU51505TN2010PLC077105
ME
MedikabazaarU51397MH2013PTC245092
T1
Tata 1mgU74140DL2015PTC279229
Latest News
- PharmEasy’s scale crosses Rs 6,600 Cr in FY23; losses down 16%Jan 30, 2024
- PharmEasy CEO has three-year lock-in, Ranjan Pai to get three board seatsNov 1, 2023
- Temasek-backed Pharmeasy’s rights issue oversubscribed, raises $420 mnNov 1, 2023
- PharmEasy’s INR 3,500 Cr Rights Issue Oversubscribed, Claims Cofounder Dhaval ShahOct 31, 2023
- Goldman may convert part-debt into equity in PharmEasyAug 30, 2023
- PharmEasy eyes Rs 3,500 Cr investment via right issueAug 23, 2023
- Exclusive: PharmEasy plans Rs 2,400-crore rights issue at 90% discount to repay loanJul 7, 2023
- Pharmeasy eyes $304 mn in funding from Manipal Group, existing investorsJul 5, 2023
- Janus Henderson cuts PharmEasy’s valuation by 50%May 15, 2023
- PharmEasy’s parent raises debt fundingNov 7, 2022